Journey Medical Corporation

NASDAQ:DERM

Drug Manufacturers - Specialty & Generic

Healthcare
$3.69 +0.99%

+$0.06 today

Market cap
$104.15M
Beta
1.10
P/E (TTM)
-17.0
EPS (TTM)
-$0.35
52W Low $4.31High $9.56

Volume 0.25M

Average 0.28M

DERM Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Journey Medical CorporationNASDAQ: DERM

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 27.31M shares rose 20.8% year over year, ahead of the +17.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 11.5% from the prior quarter. Over 3 fiscal years it compounded at +11.8% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +20.8% holds above the trailing-twelve-month pace of +17.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
27.31M+11.5% QoQ
Last fiscal yearDec 2025
24.5M+19.9% YoY
LTMMar 2026
25.01M+17.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.8%——
1 year+19.9%——
3-year CAGR+11.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
24.5M USD
Year-over-year change
+19.9%
4-year CAGR
+9.1%

Weighted Avg Shares (Diluted) vs competitors

How DERM compares with its peers on the latest reported figures

  • DERM's LTM Mar 2026 weighted avg shares (diluted) of 25.01M shares is the 9th highest of the 10 companies compared; the peer median is 38.39M shares.
  • Its year-over-year change of +17.3% is the 3rd highest of 10, against a peer median of +14.9%.
  • Over three fiscal years its annual growth of +11.8% compares with a peer median of +23.1%.
DERM Competitors Peer median
Weighted Avg Shares (Diluted) for DERM and competitors
Company Period LTM YoY 3-year CAGR
IVAInventiva S.A.FY2025186.8M +259.4%+65.2%
OGIOrganigram Global Inc.LTM Mar 2026134.1M +15.6%—
OSUROraSure Technologies, Inc.LTM Mar 202672.2M -3.1%+0.4%
NYXHNyxoah S.A.LTM Mar 202639.55M +13.3%+13.9%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 202638.39M +2.6%+14.7%
FENCFennec Pharmaceuticals Inc.LTM Mar 202630.57M +11.5%+2.8%
RNACCartesian Therapeutics, Inc.LTM Mar 202626.32M +15.6%+85.8%
HSDTSolana CompanyLTM Mar 202625.93M +788.1%+244.4%
DERMJourney Medical CorporationLTM Mar 202625.01M +17.3%+11.8%
MDWDMediWound Ltd.LTM Mar 202611.89M +14.9%+31.6%
Peer median (excluding DERM) 38.39M+14.9%+23.1%

Competitors are the stored peer set for DERM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue63.13M73.67M79.18M56.13M61.86M
Cost of Revenue32.08M30.78M26.66M20.88M25.18M
Gross Profit31.05M42.89M52.52M35.26M36.68M
Gross Margin49.2%58.2%66.3%62.8%59.3%
Research & Development16.56M10.94M7.54M9.86M480K
Selling, General & Admin39.83M59.47M43.91M40.2M44.37M
Operating Expenses65.93M70.41M54.59M48.93M44.85M
Depreciation & Amortization2.56M4.37M3.86M3.52M4.35M
EBITDA(32.77M)(23.18M)1.92M(8.4M)(3.33M)
EBITDA Margin-51.9%-31.5%2.4%-15.0%-5.4%
Operating Income(34.88M)(27.52M)(2.07M)(13.68M)(8.17M)
Operating Margin-55.2%-37.4%-2.6%-24.4%-13.2%
Interest Income2K60K322K757K589K
Interest Expense7.03M2.02M1.7M2.7M3.7M
Other Income / Expenses(7.48M)(2.05M)(1.56M)(934K)(3.2M)
Income Before Tax(42.36M)(29.57M)(3.63M)(14.61M)(11.37M)
Pre-Tax Margin-67.1%-40.1%-4.6%-26.0%-18.4%
Income Tax Expense1.63M63K221K61K60K
Net Income(43.99M)(29.63M)(3.85M)(14.67M)(11.43M)
Net Margin-69.7%-40.2%-4.9%-26.1%-18.5%
EPS (Basic)(2.54)(1.69)(0.21)(0.72)(0.47)
EPS (Diluted)(2.54)(1.69)(0.21)(0.72)(0.47)
Weighted Avg Shares17.32M17.53M18.23M20.43M24.5M
Weighted Avg Shares (Diluted)17.32M17.53M18.23M20.43M24.5M

Journey Medical Corporation

NASDAQ:DERM

Intrinsic Alpha fair value

Locked

Current Price

$3.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.